The tobacco carcinogen NNK disturbs mitotic chromosome alignment by interrupting p53 targeting to the centrosome

Area of Science:

• Oncology
• Cell Biology
• Genetics

Background:

• The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a potent carcinogen linked to lung cancer.
• While NNK's role in lung cancer is established, its precise oncogenic mechanisms remain unclear.
• Genetic mutations and chromosomal instability are observed in NNK-induced lung tumors.

Purpose of the Study:

• To elucidate the mechanisms by which NNK contributes to lung cancer progression.
• To investigate the role of p53 in NNK-induced chromosomal instability.
• To determine if p53's centrosomal localization is critical for its protective function against NNK.

Main Methods:

• Investigated NNK's effects on chromosomal stability and spindle dynamics in lung cancer cells.
• Examined the localization and function of p53 during mitosis in the presence of NNK.
• Compared NNK's impact on lung cancer cells with wild-type versus mutant p53.

Main Results:

• NNK disrupts spindle microtubule attachment to kinetochores, increasing chromosomal instability.
• NNK inhibits p53 targeting to the centrosome during mitosis, causing chromosome alignment defects.
• Lung cancer cells with wild-type p53 exhibit greater resistance to NNK than p53-mutant cells.
• Centrosomal p53, not its transcriptional activity, protects against NNK-induced chromosomal instability.

Conclusions:

• NNK promotes lung cancer progression by disrupting mitotic progression and chromosome integrity.
• p53's function at the centrosome is crucial for preventing NNK-induced chromosomal instability.
• Targeting centrosome-localized p53 may offer a therapeutic strategy for lung cancer patients with p53 mutations.